SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: BioBait who wrote (3366)9/16/2021 10:19:28 AM
From: BioBait  Read Replies (1) | Respond to of 3557
 
phe.gov

Gov limits distribution. Sad. But temporary due to limited supply



To: BioBait who wrote (3366)9/16/2021 1:08:07 PM
From: Felix B  Read Replies (1) | Respond to of 3557
 
I must have missed the section that Roche will be manufacturing 1/3 of the new order, I thought they were strictly ex-US. Does that mean they would share part of the revenue from this contract? Also wouldn't this order be reflected in Q3 earnings?

The VIR/GSK is a single antibody correct? Doesn't that mean it is more susceptible to future variants even though the current ones don't impact it?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News